316 related articles for article (PubMed ID: 18506748)
21. Pan-caner analysis identifies PSMA7 as a targets for amplification at 20q13.33 in tumorigenesis.
Sheng G; Li F; Jin W; Wang K
Sci Rep; 2024 Feb; 14(1):3034. PubMed ID: 38321088
[TBL] [Abstract][Full Text] [Related]
22. Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma.
Koynova DK; Jordanova ES; Milev AD; Dijkman R; Kirov KS; Toncheva DI; Gruis NA
Melanoma Res; 2007 Feb; 17(1):37-41. PubMed ID: 17235240
[TBL] [Abstract][Full Text] [Related]
23. Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
Fujita Y; Sakakura C; Shimomura K; Nakanishi M; Yasuoka R; Aragane H; Hagiwara A; Abe T; Inazawa J; Yamagishi H
Hepatogastroenterology; 2003; 50(54):1857-63. PubMed ID: 14696419
[TBL] [Abstract][Full Text] [Related]
24. Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells.
Chung CM; Man C; Jin Y; Jin C; Guan XY; Wang Q; Wan TS; Cheung AL; Tsao SW
Mol Carcinog; 2005 Jul; 43(3):165-74. PubMed ID: 15880741
[TBL] [Abstract][Full Text] [Related]
25. CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.
Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Meijer GA; Fijneman RJ
Cell Oncol (Dordr); 2012 Aug; 35(4):293-300. PubMed ID: 22711543
[TBL] [Abstract][Full Text] [Related]
26. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain.
Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Fijneman RJ; Meijer GA
J Pathol; 2012 Feb; 226(3):442-50. PubMed ID: 22009326
[TBL] [Abstract][Full Text] [Related]
27. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
[TBL] [Abstract][Full Text] [Related]
28. Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.
Narayan G; Scotto L; Neelakantan V; Kottoor SH; Wong AH; Loke SL; Mansukhani M; Pothuri B; Wright JD; Kaufmann AM; Schneider A; Arias-Pulido H; Tao Q; Murty VV
Genes Chromosomes Cancer; 2009 Nov; 48(11):983-92. PubMed ID: 19681120
[TBL] [Abstract][Full Text] [Related]
29. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.
Guan XY; Xu J; Anzick SL; Zhang H; Trent JM; Meltzer PS
Cancer Res; 1996 Aug; 56(15):3446-50. PubMed ID: 8758910
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome.
Douet-Guilbert N; Laï JL; Basinko A; Gueganic N; Andrieux J; Pollet B; Plantier I; Delattre C; Crépin O; Corm S; Le Bris MJ; Morel F; De Braekeleer M
Br J Haematol; 2008 Dec; 143(5):716-20. PubMed ID: 19036015
[TBL] [Abstract][Full Text] [Related]
31. Amplification at 9p in cervical carcinoma by comparative genomic hybridization.
Jee KJ; Kim YT; Kim KR; Aalto Y; Knuutila S
Anal Cell Pathol; 2001; 22(3):159-63. PubMed ID: 11455035
[TBL] [Abstract][Full Text] [Related]
32. 20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcome.
Smith LT; Mayerson J; Nowak NJ; Suster D; Mohammed N; Long S; Auer H; Jones S; McKeegan C; Young G; Bos G; Plass C; Morrison C
Genes Chromosomes Cancer; 2006 Oct; 45(10):957-66. PubMed ID: 16847944
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the topoisomerase I locus in human colorectal cancer.
Boonsong A; Marsh S; Rooney PH; Stevenson DA; Cassidy J; McLeod HL
Cancer Genet Cytogenet; 2000 Aug; 121(1):56-60. PubMed ID: 10958942
[TBL] [Abstract][Full Text] [Related]
34. Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis.
Dimova I; Yosifova A; Zaharieva B; Raitcheva S; Doganov N; Toncheva D
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):81-5. PubMed ID: 15596278
[TBL] [Abstract][Full Text] [Related]
35. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma.
Rao PH; Arias-Pulido H; Lu XY; Harris CP; Vargas H; Zhang FF; Narayan G; Schneider A; Terry MB; Murty VV
BMC Cancer; 2004 Feb; 4():5. PubMed ID: 15018632
[TBL] [Abstract][Full Text] [Related]
36. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.
Tanner MM; Tirkkonen M; Kallioniemi A; Isola J; Kuukasjärvi T; Collins C; Kowbel D; Guan XY; Trent J; Gray JW; Meltzer P; Kallioniemi OP
Cancer Res; 1996 Aug; 56(15):3441-5. PubMed ID: 8758909
[TBL] [Abstract][Full Text] [Related]
37. Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma.
Yang YC; Shyong WY; Chang MS; Chen YJ; Lin CH; Huang ZD; Wang ; Hsu MT; Chen ML
Cancer Genet Cytogenet; 2001 Nov; 131(1):48-53. PubMed ID: 11734318
[TBL] [Abstract][Full Text] [Related]
38. Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Pei J; Robu V; Feder M; Cheung M; Neumann-Domer E; Talarchek J; Dulaimi E; Millenson MM; Testa JR
Cancer Genet; 2014 Mar; 207(3):98-102. PubMed ID: 24704113
[TBL] [Abstract][Full Text] [Related]
39. Gain and overexpression of the oncostatin M receptor occur frequently in cervical squamous cell carcinoma and are associated with adverse clinical outcome.
Ng G; Winder D; Muralidhar B; Gooding E; Roberts I; Pett M; Mukherjee G; Huang J; Coleman N
J Pathol; 2007 Jul; 212(3):325-34. PubMed ID: 17516585
[TBL] [Abstract][Full Text] [Related]
40. Amplifications of oncogene erbB-2 and chromosome 20q in breast cancer determined by differentially competitive polymerase chain reaction.
Deng G; Yu M; Chen LC; Moore D; Kurisu W; Kallioniemi A; Waldman FM; Collins C; Smith HS
Breast Cancer Res Treat; 1996; 40(3):271-81. PubMed ID: 8883970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
